LPL Financial
RXRX icon

LPL Financial’s Recursion Pharmaceuticals RXRX Stock Holding History

LPL Financial’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
417,485
+6,100
+1% +$20.3K ﹤0.01% 4032
2026
Q1 		$1.26M Sell
411,385
-21,747
-5% -$84K ﹤0.01% 3960
2025
Q4 		$1.77M Buy
433,132
+34,084
+9% +$169K ﹤0.01% 3521
2025
Q3 		$1.95M Buy
399,048
+40,904
+11% +$215K ﹤0.01% 3341
2025
Q2 		$1.81M Sell
358,144
-66,946
-16% -$329K ﹤0.01% 3215
2025
Q1 		$2.25M Buy
425,090
+57,305
+16% +$418K ﹤0.01% 2844
2024
Q4 		$2.49M Buy
367,785
+7,347
+2% +$49.4K ﹤0.01% 2670
2024
Q3 		$2.38M Buy
360,438
+40,969
+13% +$294K ﹤0.01% 2563
2024
Q2 		$2.4M Buy
319,469
+111,647
+54% +$974K ﹤0.01% 2445
2024
Q1 		$2.07M Buy
207,822
+68,320
+49% +$761K ﹤0.01% 2510
2023
Q4 		$1.38M Buy
139,502
+71,092
+104% +$507K ﹤0.01% 2760
2023
Q3 		$523K Buy
68,410
+17,205
+34% +$172K ﹤0.01% 3455
2023
Q2 		$383K Buy
51,205
+15,145
+42% +$106K ﹤0.01% 3667
2023
Q1 		$241K Sell
36,060
-9,800
-21% -$77.7K ﹤0.01% 3909
2022
Q4 		$354K Buy
45,860
+4,097
+10% +$40.2K ﹤0.01% 3536
2022
Q3 		$444K Sell
41,763
-474
-1% -$4.8K ﹤0.01% 3262
2022
Q2 		$344K Buy
+42,237
New +$283K ﹤0.01% 3521

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial's RXRX Position: Q2 2026 in Review

LPL Financial increased its Recursion Pharmaceuticals (RXRX) stake by 1.5% in Q2 2026, buying an estimated $20.3K and bringing the position to 417,485 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #4032.

LPL Financial first reported a position in RXRX in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.49M in Q4 2024. 342 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • LPL Financial held 417,485 shares of Recursion Pharmaceuticals worth $1.53M as of Q2 2026.
  • LPL Financial bought 6,100 Recursion Pharmaceuticals shares in Q2 2026, an estimated $20.3K.
  • Recursion Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4032 holding.
  • LPL Financial first reported a position in Recursion Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • LPL Financial's Recursion Pharmaceuticals position peaked at $2.49M in Q4 2024.
  • 342 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.